1. Home
  2. AVD vs LCTX Comparison

AVD vs LCTX Comparison

Compare AVD & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVD
  • LCTX
  • Stock Information
  • Founded
  • AVD 1969
  • LCTX 1990
  • Country
  • AVD United States
  • LCTX United States
  • Employees
  • AVD N/A
  • LCTX N/A
  • Industry
  • AVD Agricultural Chemicals
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AVD Industrials
  • LCTX Health Care
  • Exchange
  • AVD Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • AVD 171.3M
  • LCTX 165.6M
  • IPO Year
  • AVD N/A
  • LCTX N/A
  • Fundamental
  • Price
  • AVD $6.07
  • LCTX $0.89
  • Analyst Decision
  • AVD Strong Buy
  • LCTX Strong Buy
  • Analyst Count
  • AVD 3
  • LCTX 3
  • Target Price
  • AVD $16.67
  • LCTX $5.67
  • AVG Volume (30 Days)
  • AVD 273.5K
  • LCTX 327.9K
  • Earning Date
  • AVD 11-06-2024
  • LCTX 11-07-2024
  • Dividend Yield
  • AVD 2.01%
  • LCTX N/A
  • EPS Growth
  • AVD N/A
  • LCTX N/A
  • EPS
  • AVD N/A
  • LCTX N/A
  • Revenue
  • AVD $585,049,000.00
  • LCTX $6,186,000.00
  • Revenue This Year
  • AVD N/A
  • LCTX N/A
  • Revenue Next Year
  • AVD $4.69
  • LCTX $119.00
  • P/E Ratio
  • AVD N/A
  • LCTX N/A
  • Revenue Growth
  • AVD 2.73
  • LCTX N/A
  • 52 Week Low
  • AVD $4.95
  • LCTX $0.77
  • 52 Week High
  • AVD $14.28
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • AVD 43.33
  • LCTX 48.24
  • Support Level
  • AVD $5.86
  • LCTX $0.83
  • Resistance Level
  • AVD $6.58
  • LCTX $0.94
  • Average True Range (ATR)
  • AVD 0.25
  • LCTX 0.05
  • MACD
  • AVD 0.13
  • LCTX 0.00
  • Stochastic Oscillator
  • AVD 50.00
  • LCTX 41.92

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: